Your browser doesn't support javascript.
loading
Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE).
de la Rosa, Consuelo Nóhpal; Krell, Jonathan; Day, Emily; Clarke, Aaron; Reddi, Meena; Webber, Lee; Fiorentino, Francesca.
Afiliação
  • de la Rosa CN; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK.
  • Krell J; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Day E; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK.
  • Clarke A; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Reddi M; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Webber L; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Fiorentino F; Imperial Clinical Trials Unit, School of Public Health, Imperial College London, London, UK. f.fiorentino@imperial.ac.uk.
Trials ; 23(1): 13, 2022 Jan 05.
Article em En | MEDLINE | ID: mdl-34986897

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinossarcoma Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinossarcoma Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido